As clinicians, we routinely make critical decisions for our patients with depression. Because of the uncertainty of factors that affect diagnosis and treatment, clinicians may find an objective, quick measurement tool helpful. Measurementbased care (MBC) provides specific and objective information on which to base clinical decisions and should therefore enhance quality of care and treatment outcomes. (1-3) MBC rests on these assumptions. * Compared with general questions that are typically asked during a patient evaluation, specific measurements (administered by clinicians or self-reported by patients) provide more accurate information on which to establish a diagnosis, assess treatment outcomes, and modify treatments. * Patients who complete these measurement tests will better understand their disorder and treatment effects, which will enable them to better manage their depression. * Medical records that include the results of specific measurements will assist subsequent clinicians in understanding the results of prior treatments. * The routine use of the same measurements in practice and clinical research studies will help clinicians translate research findings into their own practices. * For most outpatients with depression, self-report methods are available that are free and that take little time and effort. Diagnostic measurements Researchers have used criterion-based diagnostic methods for years. After DSM-III was introduced in 1980, the Structured Clinical Interviews for DSM-III (SCID) (and later for DSMIV) were developed to obtain lifetime diagnoses. (4,5) Briefer structured interviews were then developed, including the Mini-International Neuropsychiatric Interview (MINI), which assesses only current diagnoses, and the MINI-Plus, which elicits information about current and past diagnoses. (6-8) The MINI takes 30 to 40 minutes to administer, while the MINI-Plus may take up to 60 minutes. Studies have shown that structured or semistructured interviews provide more accurate diagnoses than typical practice. For example, clinically rendered diagnoses were compared with those made based on SCID results. (9) Major diagnostic differences were found in 40% of outpatients with clinical diagnoses of schizophrenia or bipolar or major depressive disorders. In addition, when clinicians were provided with a diagnosis that was determined using SCID, they changed the chart diagnosis in a substantial proportion of cases and prescribed fewer medications. (10) Symptom measurements Once a diagnosis has been made and therapy has been initiated, the regimen must often be modified because of intolerance, adverse effects, or other less-than-desirable symptomatic outcomes. Medication and somatic therapies are typically aimed at treating symptoms, but psychotherapy and disease self-management may also address other aspects of treatment (eg, medication adherence, social/occupational function, self-esteem). The Texas Medication Algorithm Project (TMAP) and the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) studies showed that diligent assessment of symptoms and adverse effects enhances outcomes. (11-14) The goal of therapy for depression is symptom remission and, ultimately, sustained remission and functional recovery. (15) Most patients require more than 1 treatment revision (eg, altered dosage, treatment, or delivery). When implementing guideline-driven or evidencebased care, initial treatment is continued until remission or maximal symptom improvement is obtained or until the patient cannot tolerate the regimen. Thereafter, the dosage or type of treatment may...


And finally one day, I woke up and I thought perhaps I'd had a stroke, because I lay in bed completely frozen, looking at the telephone, thinking, "Something is wrong and I should call for help," and I couldn't reach out my arm and pick up the phone and dial. And finally, after four full hours of my lying and staring at it, the phone rang, and somehow I managed to pick it up, and it was my father, and I said, "I'm in serious trouble. We need to do something."


也是这时候,大概是2015年10月的时候吧,我开始觉得自己非常不
4.2.1 老年期抑郁症 老年期常面临生活方式改变、共患病、多药治疗、居丧等情况,此期抑郁患病率较高,且常常伴随较高的自杀风险。老年期抑郁总体识别率及诊断率较低,可能原因包括:①老年人常常身体机能减退,易患各种疾病,抑郁症状常常被忽视误诊;②老年人多有不同程度的认知功能减退,使老年患者在病情认知、重视、表达等都存在缺陷,使得就诊率、诊断率偏低;③老年人怕麻烦子女,心态节约,常有淡化症状严重性倾向,不愿承认患病,否认情绪低落、兴趣下降是心境障碍。因此,疾病的早期识别和诊断尤为重要。老年期抑郁合并躯体疾病者所占比例大,常有较明显的焦虑,躯体不适主诉多,伴有一定的认知损害及偏执,失眠和食欲减退较明显。老年期抑郁治疗药物选择与一般人群大致相同,但老年人肝肾功能减退,对药物不良反应特别敏感(如低血压、抗胆碱作用),需要适当调整药物剂量,必要时可选择进行治疗药物监测。如果合并明显焦虑、失眠,可以选择抗焦虑及镇静催眠药物,包括苯二氮、丁螺环酮、佐匹克隆、艾司佐匹克隆等。
And then the anxiety set in. If you told me that I'd have to be depressed for the next month, I would say, "As long I know it'll be over in November, I can do it." But if you said to me, "You have to have acute anxiety for the next month," I would rather slit my wrist than go through it. It was the feeling all the time like that feeling you have if you're walking and you slip or trip and the ground is rushing up at you, but instead of lasting half a second, the way that does, it lasted for six months. It's a sensation of being afraid all the time but not even knowing what it is that you're afraid of. And it was at that point that I began to think that it was just too painful to be alive, and that the only reason not to kill oneself was so as not to hurt other people.
其实自己老早就感觉到有不对劲的地方,但是也没有想到会那么严重。我在美国看心理医生的时候,医 其实自己老早就感觉到有不对劲的地方,但是也没有想到会那么严重。我在美国看心理医生的时候,医生是一位年纪比较大的心理医生,也不建议我吃药,以为我会好,结果第二个冬天,我要死要活的,进了医院。以为打一针就好了,结果关了一个星期。然后各种药,中药西药维生素,心理咨询,心理医生,跑步健身减肥。各种痛,疼,头痛,脚痛,肚子痛,心绞痛,胸痛,头晕,乏力,嗜睡,每天起床身上都有至少一处不舒服,天天如此。现在身体稍微健康一点了。最大的收获就是,现在当然还会情绪低落,抑郁,但是有了各种经验,比如大姨妈要来了,事情多了,冬天来了,换环境了,女友在作,或者感觉孤独,慢慢能够意识到或者尽量寻找自己不开心的来源,然后想办法面对解决。 正视自己的感受,感觉,了解,处理面对。然后多点社交。 ... emilywong
是由两种非常有效的化合物组成的合剂。三氟噻吨是一种神经阻滞剂,根据不同剂量具有不同药理作用。大剂量的三氟噻吨主要拮抗突触后膜的多巴胺受体,降低多巴胺能活性 ;而小剂量三氟噻吨主要作用于突触前膜多巴胺自身调节受体(D2受体),促进多巴胺的合成和释放,使突触间隙中多巴胺的含量增加,而发挥抗焦虑和抗抑郁作用。四甲蒽丙胺是一种双相抗抑郁剂,可以抑制突触前膜对去甲肾上腺素及5-羟色胺的再摄取作用,提高了突触间隙的单胺类递质的含量。两种成分的合剂具有协同的调整中枢神经系统的功能,抗抑郁、抗焦虑和兴奋特性。另一方面,本药中的四甲蒽丙胺可以对抗大剂量时三氟噻吨可能产生的锥体外系症状。三氟噻吨和四甲蒽丙胺相互拮抗的结果使本药的抗胆碱能作用较四甲蒽丙胺弱。本药对上述中枢神经递质的影响,临床上也相应表现为两种成分在治疗作用方面的协同效应和副作用的拮抗效应。此外,体内及体外试验表明,本药对组胺受体有一定的拮抗作用。并且还具有镇痛、抗惊厥作用,但无抗精神病作用。
我大概是去年12月的时候,也就是2015年12月,确诊的焦虑症。不过,确诊的过程有些曲折和漫长。跟很多得过类似疾病的人一样,我也是走了很多弯路才最终确诊的。确诊之后,为了寻找病因,我仔细回忆过,发现自己大概从2014年下半年就开始出现轻微的症状了。只是那时候根本没想过会发展到这么严重的地步。一开始,我只是时常觉得头晕,鼻子不通气(我有比较严重的过敏性鼻炎),常常容易紧张(那时候准备毕业,去面试的时候总会过度紧张),常常无法集中精神,脱发也比较严重(每次洗头,手上总是满满的头发,洗一次头起码掉一百多根),经常觉得乏力,想睡觉。出现这些症状前,我曾经因为烟酒过多得过一次挺严重的急性肺炎和支气管炎。打了差不多十瓶急先锋之后,休息了七八个月才逐步恢复。但是明显能感觉到自己的体质下降了很多。于是,那段时间老是怀疑自己身体有毛病,怀疑最多的是两个,癌症(抽烟)和肾虚(脱发,乏力)。

But in 1994, three years later, I found myself losing interest in almost everything. I didn't want to do any of the things I had previously wanted to do, and I didn't know why. The opposite of depression is not happiness, but vitality. And it was vitality that seemed to seep away from me in that moment. Everything there was to do seemed like too much work. I would come home and I would see the red light flashing on my answering machine, and instead of being thrilled to hear from my friends, I would think, "What a lot of people that is to have to call back." Or I would decide I should have lunch, and then I would think, but I'd have to get the food out and put it on a plate and cut it up and chew it and swallow it, and it felt to me like the Stations of the Cross.
×